Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Advanced Medical Solutions Group plc    AMS   GB0004536594

ADVANCED MEDICAL SOLUTIONS GROUP PLC (AMS)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201520162017201820192020
Sales68,682,696,9102110118
EBITDA19,922,129,530,733,036,3
Operating profit (EBIT)17,419,525,427,729,732,9
Pre-Tax Profit (EBT)17,019,125,327,929,833,3
Net income14,115,720,121,523,926,6
P/E ratio27,130,033,928,826,324,1
EPS (GBp )6,687,389,3610,111,012,1
Dividend per Share (GBp )0,800,921,101,161,281,36
Yield0,44%0,41%0,35%0,40%0,44%0,47%
Reference price (GBp )181.25221.75317.75291291291
Announcement Date03/16/2016
07:00am
03/14/2017
07:52am
03/14/2018
06:01am
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201520162017201820192020
Debt------
Finance34,251,162,582,0102125
Operating income (EBITDA)19,922,129,530,733,036,3
Leverage
(Debt/EBITDA)
------
Capital Expenditure1,911,522,902,933,201,50
Book Value Per Share (BVPS)49,6 PNC59,1 PNC71,7 PNC80,8 PNC91,1 PNC102 PNC
Cash Flow per Share10,1 PNC9,33 PNC7,92 PNC8,21 PNC9,20 PNC10,0 PNC
Announcement Date03/16/2016
07:00am
03/14/2017
07:52am
03/14/2018
06:01am
---
Balance Sheet Analysis
Assessed data source :
© 2019 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 621 M GBP -
Entreprise Value (EV) 539 M GBP 519 M GBP
Valuation 2018e 2019e
P/E ratio (Price / EPS) 28,8x 26,3x
Capitalization / Revenue 6,10x 5,65x
EV / Revenue 5,30x 4,72x
EV / EBITDA 17,6x 15,7x
Yield (DPS / Price) 0,40% 0,44%
Price to book (Price / BVPS) 3,60x 3,19x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 27,2% 27,1%
operating Leverage (Delta EBIT / Delta Sales) 1,82x 0,93x
Net Margin (Net Profit / Revenue) 21,1% 21,7%
ROA (Net Profit / Asset) 11,9% 11,8%
ROE (Net Profit / Equities) 13,1% 12,8%
Rate of Dividend 11,5% 11,6%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   2,88% 2,91%
Cash Flow / Sales 17,2% 17,9%
Capital Intensity (Assets / Sales) 1,77x 1,84x
Financial Leverage (Net Debt / EBITDA) -2,67x -3,09x
EPS & Dividend